MiR-130a-3p Alleviates Inflammatory and Fibrotic Phases of Pulmonary Fibrosis Through Proinflammatory Factor TNF-α and Profibrogenic Receptor TGF-βRII

Pulmonary fibrosis (PF) is a progressive disease characterized by extracellular matrix (ECM) deposition that destroys the normal structure of the lung parenchyma, which is classified into two successive inflammatory and fibrotic phases. To investigate the anti-inflammatory and anti-fibrotic roles of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yan, Hou, Yapeng, Liu, Yanhong, Yu, Tong, Cui, Yong, Nie, Hongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006815/
https://www.ncbi.nlm.nih.gov/pubmed/35431964
http://dx.doi.org/10.3389/fphar.2022.863646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006815/
https://www.ncbi.nlm.nih.gov/pubmed/35431964
http://dx.doi.org/10.3389/fphar.2022.863646

Ejemplares similares